Skip to main content
Erschienen in: Reactions Weekly 1/2023

01.06.2023 | Case report

Tofacitinib

Various toxicities: 7 case reports

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Ma C, et al. REMIT-UC: Real-World Effectiveness and Safety of Tofacitinib for Moderate-to-Severely Active Ulcerative Colitis: A Canadian IBD Research Consortium Multicenter National Cohort Study. American Journal of Gastroenterology 118: 861-871, No. 5, May 2023. Available from: URL: https://journals.lww.com/ajg/pages/default.aspx Ma C, et al. REMIT-UC: Real-World Effectiveness and Safety of Tofacitinib for Moderate-to-Severely Active Ulcerative Colitis: A Canadian IBD Research Consortium Multicenter National Cohort Study. American Journal of Gastroenterology 118: 861-871, No. 5, May 2023. Available from: URL: https://​journals.​lww.​com/​ajg/​pages/​default.​aspx
Metadaten
Titel
Tofacitinib
Various toxicities: 7 case reports
Publikationsdatum
01.06.2023
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-41646-3

Weitere Artikel der Ausgabe 1/2023

Reactions Weekly 1/2023 Zur Ausgabe

Case report

Atorvastatin

Case report

Multiple drugs